Low E-Health Record Adoption Presents Challenge For R&D Use, AstraZeneca Informatics Scientist Says
Executive Summary
Adoption of EHRs “is not where it should be” to make them a valuable part of the drug R&D process, but progress is being made, according to AstraZeneca informatics scientist Sergio Eslava.
You may also be interested in...
ASCO Linking E-Health Data To Promote Real-Time Personalized Cancer Care
The American Society of Clinical Oncology takes the first big step toward a real-time learning network by aggregating data culled from electronic health records, to provide physicians, patients and others with up-to-the-minute evidence on how best to treat cancer.
HHS Seeks Suggestions On Hastening E-Health Record Interoperability, Data Exchange
Hinting that the electronic health record incentive program is not resulting in quick-enough adoption of interoperable systems, HHS asks for suggestions on how to speed up the process of making EHRs interoperable, as well as to get providers to utilize health information exchange.
Cancer Research Group Calls For EHR Link To Clinical Trial Databases
The American Association for Cancer Research recommends that meaningful use criteria include a requirement that electronic health records connect to clinical trial databases to encourage greater participation.